• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量复方新诺明对人体肾功能的损害。

Deterioration of kidney function by high doses of co-trimoxazole in man.

作者信息

Vree T B, Martea M, Hekster Y A, Termond E F, Van Klaveren R, Lammers J W, Berden J H

出版信息

Pharm Weekbl Sci. 1987 Apr 24;9(2):117-24. doi: 10.1007/BF01960746.

DOI:10.1007/BF01960746
PMID:3495779
Abstract

High doses of co-trimoxazole in a patient with Pneumocystis carinii and impaired kidney function (creatinine clearance 10 ml/min) resulted in a declining renal clearance of the drug but did not affect the average creatinine clearance. The renal clearance of sulfamethoxazole and its metabolites 5-hydroxy-, N4-acetyl-, N4-acetyl-5-hydroxysulfamethoxazole decreased 80%, while the renal clearance of trimethoprim decreased 60%. The renal clearance of all compounds was evidently dependent on urine flow. The observed phenomena may be explained by the assumption that crystalluria occurred, obstructing kidney tubules. The crystalluria effect can be reversed by cessation of the drug or by lowering its dosage.

摘要

对一名患有卡氏肺孢子虫且肾功能受损(肌酐清除率为10毫升/分钟)的患者使用高剂量复方新诺明,结果导致该药物的肾清除率下降,但未影响平均肌酐清除率。磺胺甲恶唑及其代谢产物5-羟基-、N4-乙酰-、N4-乙酰-5-羟基磺胺甲恶唑的肾清除率下降了80%,而甲氧苄啶的肾清除率下降了60%。所有化合物的肾清除率显然取决于尿流。观察到的现象可以通过存在结晶尿阻塞肾小管这一假设来解释。停药或降低药物剂量可逆转结晶尿效应。

相似文献

1
Deterioration of kidney function by high doses of co-trimoxazole in man.大剂量复方新诺明对人体肾功能的损害。
Pharm Weekbl Sci. 1987 Apr 24;9(2):117-24. doi: 10.1007/BF01960746.
2
Severe hypoglycemia associated with trimethoprim-sulfamethoxazole therapy.
J Am Board Fam Pract. 1988 Apr-Jun;1(2):143-5.
3
Pseudomembranous colitis following low dose trimethoprim-sulfamethoxazole.低剂量甲氧苄啶-磺胺甲恶唑治疗后发生的伪膜性结肠炎。
J Urol. 1985 Dec;134(6):1218-9. doi: 10.1016/s0022-5347(17)47694-4.
4
Problems with the trimethoprim-sulfamethoxazole regimen for oropharyngeal gonorrhea.用于治疗口咽淋病的甲氧苄啶-磺胺甲恶唑疗法的问题。
Mil Med. 1985 Jan;150(1):47-8.
5
Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study.甲氧苄啶-磺胺甲恶唑与喷他脒治疗获得性免疫缺陷综合征患者卡氏肺孢子虫肺炎的比较。一项前瞻性、非交叉研究。
Ann Intern Med. 1988 Aug 15;109(4):280-7. doi: 10.7326/0003-4819-109-4-280.
6
Therapy of pneumocystis carinii pneumonia after trimethoprim-sulfamethoxazole desensitization.甲氧苄啶-磺胺甲恶唑脱敏后卡氏肺孢子虫肺炎的治疗
Klin Wochenschr. 1989 Mar 1;67(5):316. doi: 10.1007/BF01892903.
7
Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole.
J Rheumatol. 1987 Feb;14(1):176-7.
8
Serum trimethoprim and sulphamethoxazole levels in AIDS.艾滋病患者血清中甲氧苄啶和磺胺甲恶唑的水平
Lancet. 1986 Apr 12;1(8485):853. doi: 10.1016/s0140-6736(86)90958-x.
9
Effect of folic and folinic acid on cytopenia occurring during co-trimoxazole treatment of Pneumocystis carinii pneumonia.
Scand J Infect Dis. 1988;20(6):685-6. doi: 10.3109/00365548809035671.
10
Neutropenia induced by short-term oral trimethoprim-sulfamethoxazole therapy; case report.
Wis Med J. 1986 Mar;85(3):19-21.

引用本文的文献

1
Pharmacokinetics of cefradine, sulfamethoxazole and trimethoprim and their metabolites in a patient with peritonitis undergoing continuous ambulatory peritoneal dialysis.
Pharm Weekbl Sci. 1987 Apr 24;9(2):110-6. doi: 10.1007/BF01960745.

本文引用的文献

1
The influence of urine flow on renal clearance of creatinine in patients with normal and impaired kidney function.尿流对肾功能正常和受损患者肌酐肾清除率的影响。
Drug Intell Clin Pharm. 1981 Mar;15(3):194-8. doi: 10.1177/106002808101500305.
2
The influence of trimethoprim, sulfamethoxazole, and creatinine on renal organic anion and cation transport in rat kidney tissue.甲氧苄啶、磺胺甲恶唑和肌酐对大鼠肾组织中肾脏有机阴离子和阳离子转运的影响。
Toxicol Appl Pharmacol. 1981 Apr;58(2):184-93. doi: 10.1016/0041-008x(81)90422-1.
3
Effect of co-trimoxazole and sulfamethoxazole on serum creatinine in normal subjects.
复方新诺明和磺胺甲恶唑对正常受试者血清肌酐的影响。
Ther Drug Monit. 1982;4(1):77-9. doi: 10.1097/00007691-198204000-00011.
4
Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function.静脉注射甲氧苄啶-磺胺甲恶唑在肾功能正常和受损的儿童及成人中的药代动力学。
Rev Infect Dis. 1982 Mar-Apr;4(2):566-78. doi: 10.1093/clinids/4.2.566.
5
The effect of co-trimoxazole on serum creatinine.复方新诺明对血清肌酐的影响。
Br J Clin Pharmacol. 1981 Nov;12(5):701-3. doi: 10.1111/j.1365-2125.1981.tb01293.x.
6
Effect of co-trimoxazole on the glomerular filtration rate of healthy adults.复方新诺明对健康成年人肾小球滤过率的影响。
Chemotherapy. 1981;27(4):229-32. doi: 10.1159/000237984.
7
Drug interference with renal function tests.药物对肾功能检查的干扰。
Am J Kidney Dis. 1983 Sep;3(2):118-20. doi: 10.1016/s0272-6386(83)80026-2.
8
[Serum creatinine concentration prior to and following trimethoprim-sulfamethoxazole (Bactrim) treatment].[甲氧苄啶-磺胺甲恶唑(复方新诺明)治疗前后的血清肌酐浓度]
Schweiz Med Wochenschr. 1974 Dec 7;104(49):1809-12.
9
Deterioration in renal function in association with co-trimoxazole therapy.
Lancet. 1973 Feb 24;1(7800):394-7. doi: 10.1016/s0140-6736(73)90251-1.
10
The effect of trimethoprim on serum creatinine.甲氧苄啶对血清肌酐的影响。
Br J Urol. 1985 Jun;57(3):265-8. doi: 10.1111/j.1464-410x.1985.tb06340.x.